Description
CagriSema is a co-formulation of Cagrilintide (amylin analog) and Semaglutide (GLP-1 agonist), studied in combination pharmacology research for convergent metabolic effects. For research use only. Not for human consumption.
← Back to compounds
GLP-1
CagriSema
$255.00 /kit
Research Overview
CagriSema 10 mg — research-grade peptide. For research use only.
Quality Metrics
Independently verified — per-lot Certificate of Analysis available in our COA library.
Related products
-
Featured
GLP-1Retatrutide
Research PeptideFrom Price range: $105.00 through $380.00 /kitSelect options This product has multiple variants. The options may be chosen on the product page -
-
-
Featured
GLP-1Semaglutide
Research PeptideFrom Price range: $55.00 through $140.00 /kitSelect options This product has multiple variants. The options may be chosen on the product page
Reviews
There are no reviews yet.